| Value | ₹0.08 Cr |
|---|
NSE filing, NSE: BOROLTD. Summary written from the filing by ALFA Finder's alert engine.
Borosil Ltd: key numbers
- Share price
- ₹241.05
- Market cap
- ₹2,883 Cr
- Revenue (annual)
- ₹1,196 Cr
- Net profit (annual)
- ₹74.66 Cr
- P/E (TTM)
- 41.1×Sector 42.1×
- Promoter holding
- 64.68%+0.00% QoQ
- FII holding
- 0.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Borosil Ltd
All →Borosil Board Meeting Date
Borosil Limited will hold a board meeting on October 29, 2026, to consider and approve its unaudited standalone and consolidated financial results.
Borosil Other Announcement
Borosil Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. This routine disclosure provides the distribution of shareholding across various categories.
Borosil Annual General Meeting
Borosil Ltd shareholders approved nine resolutions at the AGM, including a Rs. 250 crore fundraise. All proposals passed with the requisite majority via e-voting.
- Value
- ₹250.0 Cr
Borosil Other Announcement
Borosil re-appointed Chaturvedi & Shah LLP as Statutory Auditor for 60 months effective 24 September 2026. No monetary value or board decision accompanies this routine filing.
Borosil Annual General Meeting
Borosil Ltd held its 16th AGM on September 24, 2026. Shareholders voted on auditor re-appointment, MD remuneration, ESOP amendments, and a Rs. 250 crore fund-raise mandate.
Borosil Business Update
Borosil Ltd revised its Bharuch glassware manufacturing plan, shifting the facility setup to subsidiary BSL. The estimated capex will now be incurred by BSL subject to requisite approvals.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date